Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-946
Closed -$300K 525
2024
Q3
$300K Sell
946
-123
-12% -$43.8K 0.02% 397
2024
Q2
$400K Buy
1,069
+444
+71% +$150K 0.03% 329
2024
Q1
$217K Sell
625
-168
-21% -$63.7K 0.02% 431
2023
Q4
$363K Buy
793
+116
+17% +$57.2K 0.03% 319
2023
Q3
$329K Sell
677
-19
-3% -$8.93K 0.03% 312
2023
Q2
$311K Buy
696
+16
+2% +$8.05K 0.03% 301
2023
Q1
$330K Buy
680
+148
+28% +$73.2K 0.04% 268
2022
Q4
$273K Buy
532
+80
+18% +$42K 0.03% 282
2022
Q3
$219K Buy
+452
New +$220K 0.03% 298

Other funds holding HUM

Graypoint LLC's HUM Position: Q4 2024 in Review

Graypoint LLC sold out of Humana (HUM) in Q4 2024, closing a stake of 946 shares — an estimated $300K sold.

Graypoint LLC first reported a position in HUM in Q3 2022 and held it in 9 quarters. The position peaked at $400K in Q2 2024. 878 funds tracked by Wall St. Rank hold HUM as of Q4 2024.

  • Graypoint LLC reported no remaining Humana position as of Q4 2024 after selling out during the quarter.
  • Graypoint LLC sold 946 Humana shares in Q4 2024, an estimated $300K.
  • Graypoint LLC first reported a position in Humana in Q3 2022 and held it in 9 quarters.
  • Graypoint LLC's Humana position peaked at $400K in Q2 2024.
  • 878 funds tracked by Wall St. Rank held Humana as of Q4 2024.

Based on Graypoint LLC's 13F filing for Q4 2024, filed 10 Jan 2025.